Suppr超能文献

药剂师和临床药理学家在英国合作支持优化药物治疗的机会。

Opportunities for collaboration between pharmacists and clinical pharmacologists to support medicines optimisation in the UK.

机构信息

London North West Healthcare NHS trust and NHS Specialist Pharmacy Service, Visiting professor, Kingston University, London, England.

出版信息

Br J Clin Pharmacol. 2019 Aug;85(8):1666-1669. doi: 10.1111/bcp.13966. Epub 2019 May 27.

Abstract

Medicines optimisation is a clinician-driven, person-centred ongoing process. Pharmacists and clinical pharmacologists have medicines-related expertise to deliver medication review which optimises clinical and cost-effective use of medication, aligned with patient preferences, contributing to improved health outcomes. There is a large pharmacy workforce, directly accessible to patients, who can provide expert medicines-related care on the high street, and increasingly in general practice and care homes settings. There are a small number of clinical pharmacologists in practice, mainly working in a hospital setting. Potential opportunities for collaboration are extensive, including local initiatives in collaborative education, formulary/medicines management, electronic prescribing, service evaluation, research, direct clinical services as well as strategic planning through the Regional Medicines Optimisation Committees. Pharmacists and clinical pharmacologists have complementary skill sets and through acknowledging the differences in their approaches and valuing their unique skills, health services can ensure that patients are signposted to appropriate services.

摘要

药物优化是一个由临床医生驱动、以患者为中心的持续过程。药剂师和临床药理学家具有与药物相关的专业知识,可以进行药物审查,从而优化药物的临床和成本效益使用,符合患者的偏好,有助于改善健康结果。有大量的药剂师直接为患者提供服务,他们可以在高街、越来越多的普通诊所和养老院提供专业的药物相关护理。实践中只有少数临床药理学家,主要在医院工作。潜在的合作机会广泛,包括在合作教育、处方/药物管理、电子处方、服务评估、研究、直接临床服务以及通过区域药物优化委员会进行战略规划方面的本地举措。药剂师和临床药理学家具有互补的技能,通过承认他们方法上的差异并重视他们独特的技能,卫生服务机构可以确保患者被转介到适当的服务。

相似文献

1
Opportunities for collaboration between pharmacists and clinical pharmacologists to support medicines optimisation in the UK.
Br J Clin Pharmacol. 2019 Aug;85(8):1666-1669. doi: 10.1111/bcp.13966. Epub 2019 May 27.
2
Implementation of a medication therapy management collaborative within a pediatric health system.
J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4S):S114-S119. doi: 10.1016/j.japh.2018.04.021. Epub 2018 Jun 2.
3
Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic.
Eur J Hosp Pharm. 2021 Jan;28(1):10-15. doi: 10.1136/ejhpharm-2020-002364. Epub 2020 Dec 4.
4
The UK's Life Sciences Strategy: opportunities for clinical pharmacology.
Br J Clin Pharmacol. 2018 Oct;84(10):2175-2177. doi: 10.1111/bcp.13629. Epub 2018 Jun 19.
6
The future of health-system pharmacy: opportunities and challenges in practice model change.
Ann Pharmacother. 2012 Apr;46(4):S41-5. doi: 10.1345/aph.1Q805.
8
A pharmacy's journey toward the patient-centered medical home.
J Am Pharm Assoc (2003). 2011 Mar-Apr;51(2):156-60. doi: 10.1331/JAPhA.2011.10181.

引用本文的文献

1
Disentangling concepts of inappropriate polypharmacy in old age: a scoping review.
BMC Public Health. 2023 Feb 4;23(1):245. doi: 10.1186/s12889-023-15013-2.
2
An Evaluation of the Knowledge and Perceptions of Pharmacy Staff and Pre-Registration Students of E-Cigarettes Use: A Systematic Review.
Tob Use Insights. 2021 Jun 14;14:1179173X211016867. doi: 10.1177/1179173X211016867. eCollection 2021.

本文引用的文献

2
Pharmacist-led medication review in community settings: An overview of systematic reviews.
Res Social Adm Pharm. 2017 Jul-Aug;13(4):661-685. doi: 10.1016/j.sapharm.2016.08.005. Epub 2016 Aug 28.
3
Evidence based medicine: what it is and what it isn't.
BMJ. 1996 Jan 13;312(7023):71-2. doi: 10.1136/bmj.312.7023.71.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验